Abstract

<div>Abstract<p><b>Purpose:</b> If immune cells are involved in tumor surveillance and have a prognostic impact in most primary tumors, little is known about their significance in metastases. Because patients' survival is heterogeneous, even at metastatic stages, we hypothesized that immune cells may be involved in the control of metastases. We therefore characterized the tumor immune microenvironment and its prognostic value in colorectal and renal cell carcinoma (RCC) metastases, and compared it to primary tumors.</p><p><b>Experimental Design:</b> We analyzed by immunohistochemistry (<i>n</i> = 192) and qPCR (<i>n</i> = 32) the immune environments of colorectal carcinoma and RCC lung metastases.</p><p><b>Results:</b> Metastases from colorectal carcinoma and RCC have different immune infiltrates. Higher densities of DC-LAMP<sup>+</sup> mature dendritic cells (<i>P</i> < 0.0001) and lower densities of NKp46<sup>+</sup> NK cells (<i>P</i> < 0.0001) were observed in colorectal carcinoma as compared to RCC metastases, whereas densities of T cells were similar. High densities of CD8<sup>+</sup> and DC-LAMP<sup>+</sup> cells correlated with longer overall survival (OS) in colorectal carcinoma (<i>P</i> = 0.008) and shorter OS in RCC (<i>P</i> < 0.0001). High NK-cell densities were associated with improved survival in RCC (<i>P</i> = 0.002) but not in colorectal carcinoma. Densities of immune cells correlated significantly from primary to relapsing metastases for the same patient. A T<sub>H</sub>1 orientation was found in colorectal carcinoma metastases, whereas a heterogeneous immune gene expression was found in RCC metastases.</p><p><b>Conclusions:</b> Our results show a major prognostic value of the immune pattern (CD8<sup>+</sup>/DC-LAMP<sup>+</sup> cell densities) in colorectal carcinoma and RCC, reproducible from primary to metastatic tumors, although with opposite clinical impacts, and highlight the role of the tumor cell in shaping its immune environment. <i>Clin Cancer Res; 19(15); 4079–91. ©2013 AACR</i>.</p></div>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.